Latest news with #SemlerScientific
Associated Press
7 hours ago
- Business
- Associated Press
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation
New York, New York--(Newsfile Corp. - June 21, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: After trading hours on February 28, 2025, Semler Scientific filed with the SEC its 2024 annual report on Form 10-K. The annual report disclosed that on February 11, 2025, Semler Scientific 'began initial settlement discussions with DOJ [(the United States Department of Justice)], but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages. [Semler Scientific] does not believe the amount of loss can be reasonably estimated.' On this news, Semler Scientific's stock fell over 9% on the next trading day. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
Yahoo
6 days ago
- Business
- Yahoo
I tried 2 ways of investing in bitcoin. One thrived and one failed miserably, teaching me a valuable lesson.
Last December, I decided to add bitcoin exposure to my portfolio through an ETF and a single stock. The iShares Bitcoin Trust ETF has climbed double digits, while Semler Scientific has underperformed. If you're a crypto beginner looking to get exposure to bitcoin, I recommend sticking to ETFs. Back in December of 2024, I decided to hop aboard the bitcoin train and add some crypto exposure to my portfolio. Markets were flush off of the recent Trump victory, there were whispers of a national bitcoin reserve, and bitcoin had recently broken the $100,000 threshold for the first time. The cryptocurrency had gone mainstream enough for late adopters like myself to deem it investable. For my first foray into bitcoin, I purchased a share of Blackrock's iShares Bitcoin Trust Trust (IBIT). I later added a share of Semler Scientific (SMLR), a healthcare technology company that holds bitcoin on its balance sheet. I wanted to try multiple methods of investing in bitcoin. In hindsight, I realize I committed the classic retail investor impulse: buying in because of FOMO. Sure, positive investor sentiment led to gains in bitcoin, as well as the ETF I bought that was designed to track the crypto. But my stock purchase proved ill-timed. Almost six months later, bitcoin has crossed new all-time-highs, and I have mixed feelings on my investment. I opted to buy IBIT instead of actual spot bitcoin because it was a more accessible way to get exposure. I didn't want the hassle of setting up a Coinbase account. Plus, buying a single share in an ETF was more psychologically appealing than buying a tiny fraction of a bitcoin (I did not have a spare $100,000 or the risk tolerance to buy an entire bitcoin). The performance has been encouraging. Year-to-date, IBIT is up about 14%, outpacing a 12% gain for bitcoin itself. It's done its job of tracking the crypto, and even added a little extra. And it's far outperformed the S&P 500, which is up just 2% in 2025. ETFs can experience slight tracking differences due to management fees, operational costs, and the timing of inflows and outflows. But if you want a rough proxy of bitcoin performance without actually owning the underlying asset, IBIT gets the job done. A year and a half over its launch, IBIT has gained incredible popularity, growing to over $70 billion in assets under management. Robert Cannon, a financial advisor at Experity Wealth with a specialization in alternative assets, recommends his bitcoin-curious clients to start with the ETF. "It's the easiest, cleanest representation of bitcoin, compared to some of the other strategies that are a bit esoteric," Cannon told me. The ETF wrapper has really helped bitcoin adoption take off in the last year, Rahul Sen Sharma, president and co-CEO at the custom index provider Indxx, told me. Sharma's seeing a surge in interest for bitcoin and digital asset ETFs, and he believes Trump's continued support for crypto will pave the way for more mainstream adoption. Getting bitcoin exposure through other methods was indeed more esoteric — and much less profitable. I added Semler Scientific to my portfolio on January 8, 2025, and it's down more than 40% since then. There's a growing trend among companies to add bitcoin to their balance sheets, with Strategy, Tesla, and GameStop being one of the most prominent examples. The president's own Trump Media and Technology Group has recently raised $2.5 billion to buy bitcoin. Semler Scientific started adding bitcoin to its balance sheet in May of last year and now holds over 4,000 bitcoins. It sounds like a good idea in theory: holding bitcoin as a reserve asset could be a hedge against inflation and dollar weakness, and could also lead to capital appreciation as bitcoin takes off. Some companies like Strategy have had tremendous success. The firm has accumulated over half a million bitcoins, and the stock has outperformed the underlying crypto year-to-date. However, it's hard to replicate the scale and expertise of Strategy. While many of Cannon's clients often inquire about bitcoin treasury companies like Strategy, he usually recommends they stick to the basics with an ETF. There were also company-specific headwinds for Semler Scientific. The company had been under investigation from the Department of Justice for allegedly misleading claims about one of its medical devices. My takeaway from the experience is that buying a single stocks as a bitcoin proxy is probably not a good idea. When you buy into a bitcoin treasury company, you're also inheriting all of its company-specific risks. That includes everything from management decisions and financial health to legal exposure, product performance, and market sentiment around the core business. As a result, the benefits of diversification with bitcoin are watered down. If you're looking for bitcoin exposure, either buying the real thing or a spot ETF is your best bet. Maybe the strategy from here on out is to close out of my position in SMLR and do some tax-loss harvesting this year. Read the original article on Business Insider Sign in to access your portfolio
Business Insider
7 days ago
- Business
- Business Insider
I tried 2 ways of investing in bitcoin. One thrived and one failed miserably, teaching me a valuable lesson.
Back in December of 2024, I decided to hop aboard the bitcoin train and add some crypto exposure to my portfolio. Markets were flush off of the recent Trump victory, there were whispers of a national bitcoin reserve, and bitcoin had recently broken the $100,000 threshold for the first time. The cryptocurrency had gone mainstream enough for late adopters like myself to deem it investable. For my first foray into bitcoin, I purchased a share of Blackrock 's iShares Bitcoin Trust Trust (IBIT). I later added a share of Semler Scientific (SMLR), a healthcare technology company that holds bitcoin on its balance sheet. I wanted to try multiple methods of investing in bitcoin. In hindsight, I realize I committed the classic retail investor impulse: buying in because of FOMO. Sure, positive investor sentiment led to gains in bitcoin, as well as the ETF I bought that was designed to track the crypto. But my stock purchase proved ill-timed. Almost six months later, bitcoin has crossed new all-time-highs, and I have mixed feelings on my investment. Bitcoin ETFs are a beginner-friendly way to get exposure I opted to buy IBIT instead of actual spot bitcoin because it was a more accessible way to get exposure. I didn't want the hassle of setting up a Coinbase account. Plus, buying a single share in an ETF was more psychologically appealing than buying a tiny fraction of a bitcoin (I did not have a spare $100,000 or the risk tolerance to buy an entire bitcoin). The performance has been encouraging. Year-to-date, IBIT is up about 14%, outpacing a 12% gain for bitcoin itself. It's done its job of tracking the crypto, and even added a little extra. And it's far outperformed the S&P 500, which is up just 2% in 2025. ETFs can experience slight tracking differences due to management fees, operational costs, and the timing of inflows and outflows. But if you want a rough proxy of bitcoin performance without actually owning the underlying asset, IBIT gets the job done. A year and a half over its launch, IBIT has gained incredible popularity, growing to over $70 billion in assets under management. Robert Cannon, a financial advisor at Experity Wealth with a specialization in alternative assets, recommends his bitcoin-curious clients to start with the ETF. "It's the easiest, cleanest representation of bitcoin, compared to some of the other strategies that are a bit esoteric," Cannon told me. The ETF wrapper has really helped bitcoin adoption take off in the last year, Rahul Sen Sharma, president and co-CEO at the custom index provider Indxx, told me. Sharma's seeing a surge in interest for bitcoin and digital asset ETFs, and he believes Trump's continued support for crypto will pave the way for more mainstream adoption. Be careful with bitcoin treasury companies Getting bitcoin exposure through other methods was indeed more esoteric — and much less profitable. I added Semler Scientific to my portfolio on January 8, 2025, and it's down more than 40% since then. There's a growing trend among companies to add bitcoin to their balance sheets, with Strategy, Tesla, and GameStop being one of the most prominent examples. The president's own Trump Media and Technology Group has recently raised $2.5 billion to buy bitcoin. Semler Scientific started adding bitcoin to its balance sheet in May of last year and now holds over 4,000 bitcoins. It sounds like a good idea in theory: holding bitcoin as a reserve asset could be a hedge against inflation and dollar weakness, and could also lead to capital appreciation as bitcoin takes off. Some companies like Strategy have had tremendous success. The firm has accumulated over half a million bitcoins, and the stock has outperformed the underlying crypto year-to-date. However, it's hard to replicate the scale and expertise of Strategy. While many of Cannon's clients often inquire about bitcoin treasury companies like Strategy, he usually recommends they stick to the basics with an ETF. There were also company-specific headwinds for Semler Scientific. The company had been under investigation from the Department of Justice for allegedly misleading claims about one of its medical devices. My takeaway from the experience is that buying a single stocks as a bitcoin proxy is probably not a good idea. When you buy into a bitcoin treasury company, you're also inheriting all of its company-specific risks. That includes everything from management decisions and financial health to legal exposure, product performance, and market sentiment around the core business. As a result, the benefits of diversification with bitcoin are watered down. If you're looking for bitcoin exposure, either buying the real thing or a spot ETF is your best bet. Maybe the strategy from here on out is to close out of my position in SMLR and do some tax-loss harvesting this year.
Yahoo
12-06-2025
- Business
- Yahoo
Tom Lee Mulls Roughed-Up Semler Scientific for 'Granny Shot' Portfolio
The recent wave of companies adding bitcoin to their balance sheets has not yielded universally positive results. Semler Scientific (SMLR), a medical technology firm that pivoted into bitcoin treasury strategy, has seen its stock fall over nearly 50% in 2025 to nearly the level it was at a bit more than one year ago when it first began to accumulate BTC. The company's premium to its net asset value (NAV), often referred to as multiple-to-NAV (mNAV), has dropped below 1x. On a basic share count basis, its market cap sits at approximately $420 million compared to bitcoin holdings valued around $491 million (4,449 BTC), putting its NAV ratio at just 0.859x, according to Strategy-Tracker. The mNAV being below 1.0 is crucial as Semler's main mechanism for accumulating bitcoin is to raise capital via share sales. However, for the share sale strategy to be accretive to shareholders, the stock must trade at a premium to the value of the company's bitcoin holdings. With the share price at or below NAV, issuing new shares would dilute existing shareholders without adding proportional value, effectively halting the company's ability to pursue further bitcoin accumulation under the current strategy. Bitcoin bull Tom Lee, Head of Research at Fundstrat, however, views Semler Scientific as an opportunity in his firm's "Granny shot" research portfolio. Granny shot refers to an unconventional way of shooting free throws in basketball and Fundstrat's Granny Shot (GRNY) portfolio is meant to emphasize the firm's unusual approach to research.
Yahoo
11-06-2025
- Business
- Yahoo
Bitcoin Rises to $110K as Altcoins Rally; Traders Skeptical of Breakout
Bitcoin recaptured the $110,000 level for the second consecutive day, perhaps dragged higher by even larger gains among altcoins. Up 0.9% more than 1% in the last 24 hours, bitcoin was trading just above $110,000 shortly after the close of U.S. stock markets Tuesday. The CoinDesk 20 — an index of the top 20 cryptocurrencies by market capitalization, excluding stablecoins, exchange coins and memecoins — has risen 3.3% in the same period of time, mostly thanks to ether ETH, solana SOL, chainlink LINK all gaining 5%-7%. The standout performances, however, were put on by uniswap UNI and aave AAVE, which soared a whooping 24% and 13%, respectively. The move was prompted by optimistic comments on the topic of DeFi by Securities and Exchange Commission (SEC) Chair Paul Atkins on Monday. Things have remained relatively calm on the equities front, with most crypto stocks flat on the day. A notable exception is Semler Scientific (SMLR), a firm that aims to follow Strategy's (MSTR) playbook and vacuum up as much bitcoin as possible. Shares fell another 10% today, with the stock now trading for less than the value of the bitcoin on its balance sheet. Despite the day's gains, positioning across crypto markets still reflects a largely defensive tone. "Funding rates and other leverage proxies point toward a steadily cautious sentiment in the market,' Vetle Lunde, head of research at K33 Research, pointed out in a Tuesday report. "The broad risk appetite is remarkably weak, given that BTC is trading close to former all-time highs." Binance's BTC perpetual swaps posted negative funding rates on multiple days last week, with the average annualized funding rate now sitting at just 1.3% — a level typically associated with local market bottoms rather than tops, Lunde noted. "Bitcoin does not usually peak in environments with negative funding rates," he wrote, adding that past instances of such positioning have more often preceded rallies than corrections. Flows into leveraged bitcoin ETFs paint a similar picture. The ProShares 2x Bitcoin ETF (BITX) currently holds exposure equivalent to 52,435 BTC — well below its December 2023 peak of 76,755 BTC — and inflows remain muted. This defensive positioning, according to Lunde, leaves room for a potential "healthy rally" in BTC to develop. Still, not all market watchers are convinced that the current price action marks the start of a sustainable breakout. "Is this a true breakout that will continue? In my view, probably not," said Kirill Kretov, senior automation expert at CoinPanel. "More likely, it's part of the same volatility cycle where we see a rally now, followed by a sharp drop triggered by a negative announcement or some other narrative shift." According to Kretov, the current environment favors experienced traders who can navigate volatility-driven market structure. Technically, he sees BTC's next key support levels at $105,000 and $100,000 — zones that could be tested if selling pressure returns. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
